Kenneth Galbraith is CEO & Chairman at Zymeworks Inc. (ZYME). They have made 7 open-market trades across 2 companies since 2013, most recently 2026-01-12.
CIK 0001567045
1 open-market purchase totalling $750K since 2013, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZYME | 226,842 | $5.7M |
| MGNX | 6,924 | $22K |
| Total | $5.7M |
Shares reported on the most recent Form 4, priced at the 2026-01-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZYME | SELL | 2026-01-12 | 2026-01-12 | $22.67 | $690K | -0.5% | -2.2% | +11.9% |
| ZYME | SELL | 2026-01-05 | 2026-01-05 | $25.10 | $1.4M | -6.7% | -8.7% | +2.1% |
| ZYME | SELL | 2025-12-22 | 2025-12-22 | $27.02 | $2.6M | -6.6% | -12.2% | -11.9% |
| ZYME | SELL | 2025-01-06 | 2025-01-06 | $14.92 | $1.7M | -2.4% | +5.1% | -26.7% |
| ZYME | SELL | 2024-01-05 | 2024-01-08 | $10.79 | $516K | -13.8% | -1.1% | -16.1% |
| MGNX | SELL | 2020-09-09 | 2020-09-10 | $27.11 | $1.1M | -3.7% | -5.1% | -16.0% |
| MGNX | BUY | 2013-10-16 | 2013-10-18 | $16.00 | $750K | -25.4% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.